期刊文献+

LC-MS/MS法测定Beagle犬血浆中胍法辛的质量浓度 被引量:1

Determination of guanfacine in Beagle dogs plasma by LC-MS/MS
下载PDF
导出
摘要 目的建立液质联用(LC-MS/MS)方法测定Beagle犬血浆中胍法辛的药物质量浓度,从而研究胍法辛缓释片在Beagle犬体内的药动学特征。方法色谱柱为Agela C8柱(50 mm×2.1 mm,3μm),流动相为乙腈-水-甲酸(体积比20.0∶80.0∶0.01),采用液-液萃取法,以多反应离子监测(MRM)扫描方式进行检测,测定犬经口给予盐酸胍法辛缓释片后血浆中的药物质量浓度。结果Beagle犬血浆中胍法辛的药物质量浓度在0.05~20.0μg·L-1内线性关系良好,相关系数r=0.9992;日内和日间精密度的RSD≤9.0%;胍法辛的平均提取回收率在94.7%~100.9%内;胍法辛的基质效应在99.9%~107.5%内;胍法辛在犬血浆中主要药动学参数如下:t1/2为(3.5±1.3)h,ρmax为(3.72±1.37)μg·L-1,tMR 0-24为(4.9±1.6)h,tMR 0-∞为(12.2±11.4)h,AUC0-24为(18.80±4.81)μg·h·L-1,AUC0-∞为(21.63±4.76)μg·h·L-1。结论该方法快速、简便、灵敏,适用于胍法辛在Beagle犬体内的药物动力学研究。 Objective To develop a rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of guanfacine in Beagle plasma, and study the pharmacokinetics characteristic of guanfacine in Beagles plasma. Methods The chromatographic separation was accomplished on Agela C8 analytical column( 50 mm× 2.1 mm,3 μm)using a mobile phase consisting of acetonitrile-wa- ter-formic acid( V: V: V = 20.0: 80.0: 0. 01 ) at a flow rate of 0. 3 mL. min -1. Liquid-liquid extraction was used for the sample pretreatment. The plasma concentration of guanfacine was detected by multiple reactions monitoring after the Beagle dogs were given guanfacine extended-release. Results A good linear calibration curve of guanfacine was obtained over the concentration range of 0. 05- 20.0 μg·L^-1, r = 0. 999 2 ; The in- tra-and inter-day precision was both less than 9.0%. The average recoveries were between 94. 7% and 100.9%. The matrix effects were between 99.9% and 107.5%. The main pharmacokinetics parameters were as follows:t1/2 (3.5 ±1. 3) h,Pmax (3.72 ±1.37) μg·h- L^- 1,tMR0-24(4.9± 1.6)h,tMR0-∞ (12.2 ± 11.4)h, AUC0- 24 ( 18.80 ± 4. 81 ) μg·h- L^- 1, AUC0-∞ ( 21.63± 4.76 ) μg·h- L^- 1, respectively. Conelusions This simple and sensitive LC-MS/MS method is successfully applied to the pharmacokinetics studies of guan- facine in Beagle dogs' plasma.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2014年第10期813-818,共6页 Journal of Shenyang Pharmaceutical University
关键词 胍法辛 液质联用法 药动学 guanfacine LC-MS/MS Beagle dog pharmacokinetics
  • 相关文献

参考文献11

  • 1TAYLOR F B,RUSSO J.Comparing guanfacine and dextroamphetamine for the treatment of adult attentiondeficit/hyperactivity disorder[J].J Clin Psychopharmacol,2001,21(2):223-228.
  • 2马培奇.美FDA批准盐酸胍法辛缓释片Intuniv治疗儿童和青少年注意力缺乏和多动症[J].上海医药,2009,30(10):478-478. 被引量:2
  • 3GUERRET M,LAVENE D,LONGCHAMPT J,et al.Determination of guanfacine in biological fluids by electron-capture GLC[J].J Pharm Sci,1979,68(2):219-221.
  • 4CARRIE H,CARL W,ALPHONSE P,et al.A novel method for the determination of guanfacine in urine by gas chromatography-mass spectrometry[J].J Anal Toxicol,2008,32(8):544-546.
  • 5WOLF C E,KESTER-FLORIN S J,POKLIS A,et al.A HPLC-MS method to detect and quantify guanfacine in urine[J].Clin Chem Lab Med,2011,50(3):535-537.
  • 6YUAN Yuan-li,JACK H,RICHARD A,et al.Dried blood spots as a sampling technique for the quantitative determination of guanfacine in clinical studies[J].Bioanalysis,2011,3(22):2501-2514.
  • 7YUAN Yuan-li,JACK H,RICHARD A,et al.Semi-automated direct elution of dried blood spots for the quantitative determination of guanfacine in human blood[J].Bioanalysis,2012,4(12):1445-1456.
  • 8XIAO Nan-li,NING Li,XIAO Lin-sun,et al.Development and validation of a simple,sensitive and accurate LC-MS/MS method for the determination of guanfacine,a selectiveα2A-adrenergicreceptor agonist,in plasma and its application to a pharmacokinetic study[J].Biomed Chromatogr,2013,27:1708-1713.
  • 9刘平,赵登职,徐艳华.胍法辛缓释片在比格犬体内的药动学研究[J].中国新药杂志,2013,22(21):2538-2541. 被引量:3
  • 10SURYANARAYANA M G,YADAGIRI S M N,CHANDRASEKHER B K,et al.Method development and validation of guanfacine in rat plasma by liquid chromatography-tandem mass spectrometry:Application to a pharmacokinetic study[J].J Pharm Anal,2013,3(6):472-480.

二级参考文献12

  • 1KOLAR D, KELLER A, GOLFINOPOULOS M,et al. Treatmentof adults with attention-deficit/hyperactivity disorder [ J ]. Neuro-psychiatr Dis Treat ,2008 , 4(2) :389 -403.
  • 2SPENCER TJ,GREENBAUM M, GINSBERG LD,e( al. Safetyand effectiveness of coadministration of guanfacine extended re-lease and psychostimulants in children and adolescents with atten-tion-deficit/hyperactivity disorder [ J ]. J Child Adolesc Psycho-pharmacol,2009,19(5) : 501 -510.
  • 3SALLEE FR, KOLLINS SH , WIGAL TL. Efficacy of guanfacineextended release in the treatment of combined and inattentive onlysubtypes of attention-deficit/hyperactivity disorder [ J ]. J ChildAdolesc Psychopharmacol, 2012 , 22(3) :206 - 214.
  • 4ARNSTEN AF, JIN LE. Guanfacine for ihe treatment of cognitivedisorders: A century of discoveries at Yale[ J]. Yale J Biol Med,2012,85(1) : 45 -58.
  • 5BLANKENSHIP K, ERICKSON CA, STIGLER KA,et al.Guanfacine extended release in two patients with pervasive devel-opmental disorders [ J ]. J Child Adolesc Psychopharmacol, 2011,21(3) :287 -290.
  • 6CONNOR DF, FINDLING RL, KOLLINS SH,ei al. Effects ofguanfacine extended release on oppositional symptoms in childrenaged 6-12 years with attention-deficit hyperactivity disorder andoppositional symptoms : a randomized,double-blind,placebo-controlled trial[ J] . CNS Drugs,2010, 24(9) : 755 -768.
  • 7CHILDRESS AC. Guanfacine extended release as adjunctivetherapy to psychostimulants in children and adolescents with at-tention-deficit/hyperactivity disorder [ J ]. Adv Ther, 2012,29(5):385 -400.
  • 8SALLEE FR, KOLLINS SH,WIGAL TL. Efficacy of guanfacineextended release in the treatment of combined and inattentive onlysubtypes of attention-deficit/hyperactivity disorder [ J ]. J ChildAdolesc Psychopharmacol y2Ql2 , 22(3) ; 206 - 214.
  • 9CRUZ MP. Guanfacine extended-release tablets ( Intuniv) , anonstimulant selective alpha2A-adrenergic receptor agonist for at-tention-deficit/hyperactivity disorder[ J]. P T, 2010,35 (8):448 -451.
  • 10SWEARINGEN D, PENNICK M,SHOJAEI A,et al. A phaseI,randomized, open-label, crossover study of the single-dosepharmacokinetic properties of guanfacine extended-release 1 -, 2-,and 4-mg tablets in healthy adults [ J ]. Clin Ther,2007 , 29(4): 617 -625.

共引文献2

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部